Clinical Trial Update: PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease [Phase 1]

View source ↗

Summary

Phase 1 study reporting pharmacokinetic and pharmacodynamic responses to oral L-Citrulline in patients with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Angiogenix | Conditions: Sickle Cell Disease | Phase 1 | Status: UNKNOWN